The lipid-rich cell wall of mycobacteria is essential not only for virulence but also for survival. Whilst anabolic pathways for mycobacterial lipid biosynthesis have been well studied, there has been little research looking into lipid catabolism. The genome of Mycobacterium tuberculosis encodes multiple enzymes with putative roles in the b-oxidation of fatty acids. In this report we explore the functionality of FadB2, one of five M. tuberculosis homologues of a b-hydroxybutyrylCoA dehydrogenase, an enzyme that catalyses the third step in the b-oxidation cycle. Purified M. tuberculosis FadB2 catalysed the in vitro NAD + -dependent dehydration of b-hydroxybutyryl-CoA to acetoacetyl-CoA at pH 10. Mutation of the active-site serine-122 residue resulted in loss of enzyme activity, consistent with the function of FadB2 as a fatty acyl dehydrogenase involved in the b-oxidation of fatty acids. Surprisingly, purified FadB2 also catalysed the reverse reaction, converting acetoacetyl-CoA to b-hydroxybutyryl-CoA, albeit in a lower pH range of 5.5-6.5. Additionally, a null mutant of fadB2 was generated in Mycobacterium smegmatis. However, the mutant showed no significant differences from the wild-type strain with regard to lipid composition, utilization of different fatty acid carbon sources and tolerance to various stresses; the absence of any phenotype in the mutant strain could be due to the potential redundancy between the five M. smegmatis fadB paralogues.
INTRODUCTION
Mycobacterium tuberculosis, the causative agent of tuberculosis, is estimated to kill 1.6 million people every year (WHO, 2007) . With the evolution of drug-resistant strains and the recent report of a strain resistant to all known drugs, there is an urgent need for effective new antituberculosis therapies and novel drug targets (Velayati et al., 2009) . Presently, some of the most successful antitubercular treatments currently used target lipid metabolism, for example isoniazid, which targets mycolic acid biosynthesis (Takayama et al., 1972) . The importance of lipids in mycobacteria is seen by the unusually high lipid content of the cell wall and the vast number of genes involved in lipid metabolism, as revealed by analysis of the complete genome sequence (Cole et al., 1998) .
Despite lipid biosynthesis having been well studied in mycobacteria (Bhatt et al., 2007; Heath & Rock, 2004; Takayama et al., 1972) , the extensive field of lipid degradation has not yet been investigated with equal intensity. The chemistry of the b-oxidation pathway is similar to the reverse of lipid biosynthesis. Saturated long-chain fatty acids are first activated by CoA attachment and subsequently undergo oxidation by an acyl-CoA dehydrogenase. This is followed by hydration catalysed by an enoyl-CoA hydratase to produce b-hydroxyacyl-CoA. The hydroxy group is further oxidized to form a b-ketoacyl-CoA, which is then finally cleaved by a b-ketoacyl-CoA thiolase, releasing acetyl-CoA and a saturated fatty acid that is two carbons shorter (Black & DiRusso, 1994) . While playing a general role in fatty acid turnover, in mycobacteria fatty acid boxidation may have a specific relevance for the physiology of the bacterium during survival within the hypoxic niche of a granuloma, a critical site of chronic infection. The glyoxylate cycle, which utilizes acetyl-CoA (produced by b-oxidation) to generate glucose by conserving the two carbon atoms lost as 2 CO 2 in the TCA cycle, is crucial for the persistence of M. tuberculosis in the mouse model of infection (McKinney et al., 2000) . Additionally, several studies have indicated that host-derived fatty acids could be a key source of carbon for the bacteria (Bloch & Segal, 1956; Bishai, 2000; , suggesting that infecting mycobacteria favour exploiting the lipid-rich environment of host tissues over synthesizing their own lipids de novo (Wheeler et al., 1990; Wheeler & Ratledge, 1994) . converts the b-hydroxy group to a b-keto group using NAD + as a cofactor. Unlike in Escherichia coli, where the fadA and fadB genes form a single operon encoding the two proteins of the b-oxidation multi-enzyme complex (DiRusso, 1990) , in M. tuberculosis there are five discrete fadB genes and six fadA genes. Recently, Mt-FadA5 has been shown to catalyse the thiolysis of cholesterol, although the function(s) of the other five fadA genes are yet to be elucidated (Nesbitt et al., 2009) . FadB1 is thought to perform the second step in the pathway, involving conversion of the trans-2-enoyl to the bhydroxy group, but the function(s) of FadB2, B3, B4 and B5 remain unknown. This may suggest a certain degree of redundancy amongst the FadB enzymes, especially as only FadB3 has been described as essential . The Mt-FadB2 sequence is homologous to the products of the Mycobacterium smegmatis gene MSMEG0912 and the Mycobacterium leprae gene Ml_2461, and to sections of the E. coli and Psuedomonas fragi FadB enzymes (Fig. 1A, B) . It is possible that the FadB enzymes are chain length specific, like the short-, medium-and long-chain b-hydroxyacylCoA dehydrogenases found in mammalian mitochondria (El-Fakhri & Middleton, 1982; McGuire et al., 1990) . One interesting feature of the fadB2 gene is that it is conserved across mycobacteria, and is located in the genome adjacent to icl1 (Fig. 1B) . This gene encodes the glyoxylate shunt enzyme isocitrate lyase, which has been shown to promote persistence of M. tuberculosis cells in an infected host (McKinney et al., 2000) . Prior to the sequencing of the first M. tuberculosis genome, H 37 Rv, a b-hydroxyacylCoA dehydrogenase enzyme from Mycobacterium smegmatis had also been characterized using a purified protein fraction containing b-hydroxyacyl-CoA dehydrogenase activity (Shimakata et al., 1979) . This and a previous study by the same group led to the conclusion that the enzyme was involved in the acetyl-CoA-dependent elongation of fatty acids, but failed to provide evidence for its involvement in fatty acid b-oxidation (Shimakata et al., 1977) . This present study describes the cloning of M. tuberculosis b-hydroxyacyl-CoA dehydrogenase, Mt-FadB2, its overexpression in E. coli and its purification, which has allowed for detailed protein characterization and kinetic studies. In parallel, a mutant of the fadB2 homologue in the surrogate M. smegmatis was also generated, in order to explore the functional role of fadB2.
METHODS
In silico analysis of Mt-FadB2. The FadB2 nucleotide and protein sequences were obtained from TubercuList (http://genolist.pasteur.fr/ TubercuList/). CLUSTAL W (Labarga et al., 2007) and ESPript (Gouet et al., 1999) were used to produce multiple sequence alignments of b-hydroxyacyl-CoA dehydrogenase from various species. The ProtParam tool from the Swiss Institute of Bioinformatics ExPASy Server was used for primary sequence analysis (Gasteiger et al., 2005) and GOR IV was used to predict the secondary protein structure (Garnier et al., 1996) .
Plasmids and DNA manipulation. The E. coli-compatible vector pET28b (Novagen) containing a T7 promoter and encoding both Nand C-terminal 6-histidine tags was used for the overexpression of Mt-FadB2. All PCR amplifications were executed using Vent DNA polymerase (New England Biolabs) and M. tuberculosis H 37 Rv chromosomal DNA. Mt-FadB2 PCR amplification was performed using the upstream primer 59-GATCGATCCATATGGTGAGCGA-TGCGATCCAGCGG-39 and the downstream primer 39-GATC-GATCAAGCTTGTACGTGTAGAAACCTCGACC-59, which contain NdeI and HindIII restriction sites respectively (underlined). The 858 bp PCR product was then doubly digested with NdeI/HindIII and ligated into a similarly cut pET28b plasmid, yielding pET28b-MtFadB2. DNA sequencing was used to verify the recombinant gene.
Construction of the Mt-FadB2 S122A mutant. The Stratagene QuikChange Multi Site-Directed Mutagenesis kit was used to create a pET28b-Mt-fadB2(S122A) plasmid. The following primers were used to introduce the mutation into the pET28b-Mt-fadB2 plasmid template: 59-TGGCGTCGAATACCGCCAGCATCCCGATC-39 and 59-GATCGGGATGCTGGCGGTATTCGACGCCA-39. The ensuing PCR and transformation were performed according to the kit manual. Sequencing was used to confirm that the mutation had been made.
Overexpression of wild-type and S122A Mt-FadB2. The pET28b-Mt-fadB2 plasmid was transformed into E. coli C43 (DE3) cells and incubated on LB agar containing 25 mg ml 21 kanamycin overnight at 37 uC. One colony was used to inoculate LB broth (5 ml) containing kanamycin (25 mg ml 21 ) and cultures were incubated on a rotary incubator at 37 uC overnight. This mini-culture was used to inoculate Terrific broth (1 l) containing kanamycin (25 mg ml 21 ) and was incubated on a rotary incubator (180 r.p.m.) at 37 uC until the OD 600 had reached~0.6. At this point, the culture was induced by the addition of 1 mM IPTG and incubated with shaking for 16 h at 16 uC. The cells were harvested by centrifugation at 4500 g for 12 min and stored at 220 uC for purification. Overexpression of the Histagged Mt-FadB2 was confirmed by Western blot analysis using mouse monoclonal Penta-His antibody (Qiagen).
Purification of wild-type and S122A Mt-FadB2 protein. Pelleted cells of the wild-type and the Mt-FadB2 S122A mutant were resuspended in buffer A (0.02 M sodium phosphate, pH 7.9, 0.5 M NaCl) and lysed by probe sonication (10 cycles of 30 s pulses followed by 30 s cooling intervals). The crude lysate was centrifuged at 27 000 g for 40 min at 4 uC to remove the insoluble components and the resulting clarified lysate was applied to a Ni 2+ -charged 5 ml HisTrap HP affinity column (GE Healthcare). The column was washed with 10 column volumes of buffer A and the protein was eluted with a stepwise imidazole gradient of 50 mM (50 ml), 130 mM (10 ml) and 1 M (10 ml). The fractions were analysed by 12 % SDS-PAGE followed by Coomassie staining. A large single band at 30 kDa on SDS-PAGE demonstrated the purity of the protein and Mt-FadB2 was correctly identified by trypsinization digest and mass spectrometry. The fractions containing pure Mt-FadB2 protein were dialysed, first against 50 mM potassium phosphate (pH 7.9), 50 mM NaF, with 1 mM EDTA added to remove any leached Ni
2+
, and then twice against 50 mM potassium phosphate (pH 7.9), 50 mM NaF at 4 uC. The potassium phosphate/NaF buffer was chosen because it provided optimal conditions for circular dichroism experiments. Mt-FadB2 concentration was determined using a BCA Protein Assay kit (ThermoScientific); a total of 18 mg protein could be obtained from a 1 l culture. The purified protein was stored at 280 uC both with and without the addition of 10 % glycerol. is compared with those of homologues in M. smegmatis (Ms_0912, accession no. ABK71785), M. leprae (Ml_2461, accession no. CAC31978), E. coli (Ec_FadB, accession no. AAC76849 residues 297-624) and Pseudomonas fragi (Pf_FadB accession no. 2D3T_A) as well as the other M. tuberculosis FadB-annotated proteins: FadB1 (accession no. CAA17666 residues 310-633) and FadB3 (accession no. CAE55415). The figure was generated using CLUSTAL W and ESPript (available from http:// expasy.ch/), and data for the corresponding secondary structure for P. fragi FadB (residues 270-575) were obtained from the Protein Data Bank. Red-filled boxes indicate residues conserved across all the species aligned and blue-boxed residues are those of high similarity. The triangles indicate the putative NAD Enzyme assay for wild-type and S122A Mt-FadB2. The activity assay for Mt-FadB2 was based on that previously described (Nemeria et al., 2001) . The forward Mt-FadB2-dependent reduction of NAD + to NADH was monitored spectrophotometrically at 340 nm using a Jenway 6 7 10 spectrophotometer. The standardized 1 ml reaction contained 100 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) buffer (pH 9.5), 50 mM NAD + , 50 mM b-hydroxybutyrylCoA and 7 mg purified Mt-FadB2 protein. The reaction mixture minus the protein was incubated for 2 min at 30 uC before adding the enzyme to start the reaction. The reverse reaction was observed similarly. The standard 1 ml reaction contained 100 mM potassium phosphate buffer (pH 7.0), 50 mM NADH, 50 mM acetoacetyl-CoA and 7 mg pure Mt-FadB2 protein. All controls were performed to ensure that neither the potassium phosphate/NaF buffer nor any of the assay buffers or substrates interfered with the assay results. All reactions were monitored for a long enough period to obtain an accurate rate. The kinetic parameters K m , V max and k cat for each substrate and cofactor were ascertained by varying their concentration and fitting the data to the Michaelis-Menten equation and using SigmaPlot 8.0. Each reaction was performed in triplicate.
Circular dichroism (CD) spectroscopy. All CD far-UV spectra were obtained at 25 uC using a Jasco J-715 spectropolarimeter and a 0.01 cm pathlength cell. The wild-type and S122A-mutant Mt-FadB2 proteins were made to 1.1 mg ml 21 as determined by the BCA Protein Assay kit. To compare the folding of the wild-type and mutant protein, 50 mM potassium phosphate (pH 7.9), 50 mM NaF buffer was used. To assess protein folding at different pH values, 50 mM potassium phosphate (pH 6, 7 or 8), 50 mM NaF or 50 mM CAPS (pH 9, pH 10 or pH 11), 50 mM NaF was used. Each condition was scanned eight times over a wavelength of 197-245 nm and a bandwidth of 2 nm. The results were normalized by subtracting the baseline buffer spectrum from each.
Construction of the M. smegmatis fadB2 deletion mutant. The M. smegmatis knockout mutant was generated using the method previously described (Bardarov et al., 2002) . A 1000 bp sequence of the upstream region of Ms-fadB2 and an 800 bp sequence of the downstream region of Ms-fadB2 were PCR amplified using M. smegmatis mc 2 155 genomic DNA, Phusion DNA polymerase (Finnzymes) and the following primers, each containing a DraIII restriction site at the 59 end (underlined): Ms-fadB2_LL (59-TTTTTTTTCACAAAGTGCTGGAGCCCTGCATCGCGCG-39), MsfadB2_LR (59-TTTTTTTTCACTTCGTGCGGGATGCTCGACGTGT-TCG-39), Ms-fadB2_RL (59-TTTTTTTTCACAGAGTGCTGCTCTC-GGCAATCCGCAT-39) and Ms-fadB2_RR (59-TTTTTTTTCACCT-TGTGCTTCCCAACCCTGCAGGCGG-39). The PCR fragments were cloned in the vector p0004S to generate the allelic-exchange plasmid pDMs-fadB2, which was then PacI-digested and packaged into the mycobacteriophage phAE159 to generate the knockout phage phDMsfadB2. High-titre phage particles were produced and transduced into wild-type M. smegmatis mc 2 155 cells as previously described (Bardarov et al., 2002) . Hygromycin-resistant colonies obtained after transduction were confirmed as Ms-fadB2-deletion mutants by Southern blotting.
Construction of the complemented DMs-fadB2 strains. The E. coli-Mycobacterium shuttle vector pMV261 was used for complementation (Stover et al., 1991) . Ms-fadB2 was amplified from M. smegmatis mc 2 155 chromosomal DNA using Phusion DNA polymerase. The upstream primer (59-GATCGATCGGATCCAGTGAGC-AATGCAATCGAACGA-39) contained a BamHI restriction site (underlined) and the downstream primer (39-GATCGATCAAGC-TTTCAGTAGGTATAGAAGCCCTT-59) a HindIII restriction site (underlined). Mt-fadB2 PCR amplification was performed using M. tuberculosis H 37 Rv genomic DNA, the upstream primer 59-GATCGATCGGATCCAGTGAGCGATGCGATCCAGCGG-39 and the downstream primer 39-GATCGATCAAGCTTATCAGTACGTGTAG-AAACCTCG-59, which contain BamHI and HindIII restriction sites respectively (underlined). The PCR products were then digested with BamHI and HindIII and ligated into a similarly cut pMV261 plasmid, yielding pMV261-Ms-fadB2 and pMV261-Mt-fadB2. DNA sequencing was used to verify the recombinant genes. Electrocompetent DMs-fadB2 mutant cells were electroporated with pMV261-Ms-fadB2, pMV261-Mt-fadB2 or pMV261 plasmid and transformants were selected for using hygromycin (100 mg ml
21
) and kanamycin (25 mg ml
).
Growth analysis of the M. smegmatis fadB2 deletion mutant.
Wild-type M. smegmatis, DMs-fadB2, and pMV261-Ms-fadB2-and pMV261-Mt-fadB2-complemented transformants were grown to saturation in minimal medium (MM) plus 0.1 % glucose. The MM used was based on that of Chang et al. (2009) 
RESULTS AND DISCUSSION

In silico analysis of Mt-FadB2
Mt-FadB2 has a higher than average proportion of charged amino acids (24.1 %) compared to the entire M. tuberculosis proteome (20.0 %), the majority of which being negatively charged (Asp+Glu, 13.3 %) (Luthra et al., 2008) . Similarly, there are more hydrophobic residues (34.1 %) than polar residues. The high percentage of charged and polar residues suggests that the protein is soluble and therefore not an integral cell membrane protein. The theoretical pI of the native protein is calculated as 5.2, whereas that of the recombinant protein used here is calculated as 6.1 (Gasteiger et al., 2005) .
Alignment of b-hydroxyacyl-CoA dehydrogenases from mycobacteria and other species highlights the conserved residues of the hypothetical catalytic triad as identified by Barycki et al. (1999) (Fig. 1A) . The residues annotated with triangles are consistent with the sequence of a Rossmann fold, a structural motif known to bind NAD + . This is supported by the computed GOR IV secondary structure (Garnier et al., 1996) , which predicts a b-sheet-a-helix-bsheet motif at the C terminus, a feature that is also seen in the overlaid secondary structure from the Pseudomonas fragi FadB protein. Mt-FadB2 has high identity to MtFadB3 and part of the Mt-FadB1 protein (alignment scores 444 and 485 respectively; data not shown). The identity between Mt-FadB2, -FadB4 and -FadB5 from M. tuberculosis, however, is much less (alignment scores 13 and 0 respectively) and Mt-FadB4 and -FadB5 do not share the same NAD + -binding site or hypothetical catalytic triad residues (data not shown). This may indicate redundancy between Mt-FadB1, -FadB2 and -FadB3 but alternative role(s) for Mt-FadB4 and -FadB5.
Mt-FadB2 is an enzymically active b-hydroxybutyryl-CoA dehydrogenase
In an effort to demonstrate enzymic activity of Mt-FadB2, a spectrophotometric assay was developed, which involved monitoring the reduction of the cofactor NAD + at 340 nm ( Fig. 2A-E) . The kinetic parameters calculated from the data using SigmaPlot 8.0 are displayed in Table 1 . The activity for the NAD + -dependent dehydrogenase reaction was tested over a range of temperatures and pH values and the optima were found to be 37 u C and pH 10 (CAPS buffer), respectively (Fig. 3A) . While it was not unexpected to find that Mt-FadB2 was most active at the physiological temperature of the M. tuberculosis mammalian host, it was more surprising that the enzyme appeared to work best in alkaline conditions, given the acidic nature of the bacteriacontaining phagolysosomal compartment in macrophages. However, the same result has been obtained by Shimakata et al. (1979) , who purified a protein fraction containing bhydroxyacyl-CoA dehydrogenase activity from M. smegmatis. CD spectra revealed that the protein is more susceptible to unfolding when in acidic conditions than at high pH values; the tertiary structure is maintained even at pH 10 (Fig. 5B) . Nevertheless, it is likely that the optimal pH for in vivo activity may be different from those obtained with purified protein, especially knowing that the pI values of the native and recombinant protein are different.
Furthermore, Mt-FadB2 NAD + -reducing activity was found to be non-metal-dependent; however, various uni-and divalent cations were tested to see if their presence inhibited or activated the protein. Mg  2+ and Ca 2+ enhanced the activity of the enzyme, whereas Zn 2+ , Ni 2+ and Co 2+ had an inhibitory effect (Fig. 4) . The enzyme was not active when NADP + was used as a cofactor, even in the presence of CaCl 2 (data not shown). Liu et al. (2004) found that by substituting the Ser-137 residue with an alanine in rat mitochondrial b-hydroxyacyl-CoA dehydrogenase the activity was greatly reduced, demonstrating that Ser-137 was a key catalytic residue (Fig. 1) . Generation of the equivalent mutation in MtFadB2 (S122A) abolished all activity, supporting the idea that Mt-FadB2 is indeed a b-hydroxyacyl-CoA dehydrogenase. CD far-UV (197-245 nm) spectra of the wild-type and mutant protein were obtained to confirm the correct folding of both proteins (Fig. 5A) . As well as showing that the mutation did not cause any changes to the secondary structure, this result strongly indicates that Ser-122 is a key active-site residue of Mt-FadB2 that is directly involved in catalysis.
The reverse reaction
We also investigated whether Mt-FadB2 could catalyse the reverse reaction, converting acetoacetyl-CoA to b-hydroxybutyryl-CoA, using NADH as the cofactor (Fig. 2C , E, Table 1 ). Shimakata et al. (1979) could not conclude that their protein with b-hydroxyacyl-CoA dehydrogenase activity was involved in fatty acid b-oxidation, but their results did show that the dehydrogenase was involved in the fatty acid elongation system. Wheeler et al. (1991) also implied the same conclusions in mycobacteria by showing that other enzymes of the b-oxidation pathway could catalyse both forward and reverse reactions. We tested this reverse reaction over a range of pH values and the optimum was found to be pH 5.5-6.5 (potassium phosphate buffer) (Fig. 3B) , a result that has been previously described for b-hydroxyacyl-CoA dehydrogenase (Shimakata et al., 1979) . The enzyme kinetics for MtFadB2 indicate that the protein has a slightly greater affinity for b-hydroxybutyryl-CoA than acetoacetyl-CoA, in other words, the fatty acid catabolism direction. However, the fact that the NADH-oxidation reaction was found to be optimum at the pH inside the macrophage vacuole could suggest that this 'reverse' reaction is favoured in vivo and the dehydrogenase is utilized by the bacteria to synthesize, or elongate, fatty acids rather than degrade them. We also found that whereas the forward reaction could not use NADP + as the cofactor, the reverse reaction was able to use NADPH as well as NADH. This therefore also indicates a role for Mt-FadB2 in lipid synthesis and fatty acid elongation.
M. smegmatis fadB2 deletion mutant analysis
The Ms-fadB2 knockout mutant was generated using specialized transduction (Bardarov et al., 2002) and confirmed by Southern blotting (data not shown). This verified that the gene is not essential in M. smegmatis, as suggested by transposon data reported for M. tuberculosis . No obvious differences were observed either in colony morphology or lipid profiles between the Table 1 . Kinetic parameters of Mt-FadB2 as determined by spectrophotometric assay and doublereciprocal plots
The standardized 1 ml forward reaction contained 100 mM CAPS buffer (pH 9.5), 50 mM NAD + , 50 mM b-hydroxybutyryl-CoA and 7 mg purified Mt-FadB2 protein. The reverse reaction (1 ml) contained 100 mM potassium phosphate buffer (pH 7.0), 50 mM NADH, 50 mM acetoacetyl-CoA and 7 mg pure Mt-FadB2 protein.
In all cases the reaction mixture minus the protein was incubated for 2 min at 30 uC before adding the enzyme to start the reaction and NADH or NAD + production, respectively, was monitored at 340 nm. Values are means of three replicates with the standard error shown in parentheses. Taking either b-hydroxybutyryl-CoA (A) or acetoacetyl-CoA (B) as the substrate, the reactions were assayed spectrophotometrically as described in the text. For pH values with low activity, the reaction was monitored for a long enough period to obtain a rate. Points are the mean±SE of three replicates. 155 (data not shown). Growth of the DMs-fadB2 mutant on minimal medium containing a variety of carbon sources was compared to that of the wild-type and complemented strains. No difference in growth was observed between any of the strains when grown on agar media containing glycerol, glucose, acetate, propionate, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, oleic acid or linoleic acid as the sole carbon source. Following the recent report on a mycobacterial FadA enzyme, which acts as a thiolase in cholesterol metabolism, we also tested the growth of the Ms-fadB2 deletion mutant on minimal medium containing cholesterol as the sole carbon source. However, in this case too, no differences were observed in the growth of the wild-type and mutant strains.
Previously it has been shown that Mt-fadB2 is upregulated upon acid shock and SDS stress (Fisher et al., 2002; Manganelli et al., 2001) . To test whether FadB2 conferred tolerance to these stresses, the DMs-fadB2 mutant was grown in media of various pH values or containing different concentrations of SDS. We found, however, that the deletion had no effect on cell growth rate and survival at physiological pH, and under acid and SDS stress.
Given the presence of an additional four putative fadB genes in the genome of M. smegmatis (homologues of the M. tuberculosis genes fadB1, B3, B4 and B5), it was quite likely that the effects of loss of Ms-fadB2 were masked due to a redundancy between orthologous Ms-fadB genes. Under these circumstances, the generation of double or multiple fadB knockout strains would be ideal for studying the roles of these genes in the biology of mycobacteria and is currently under way. . CD spectra (A) Superimposed CD spectra of wild-type Mt-FadB2 and S122A-mutated Mt-FadB2 in 50 mM potassium phosphate (pH 7.9), 50 mM NaF buffer. (B) Superimposed CD spectra of wild-type Mt-FadB2 in different pH buffers [50 mM potassium phosphate (pH 6, 7 or 8), 50 mM NaF or 50 mM CAPS (pH 9, 10 or 11), 50 mM NaF]. Protein samples (1.1 mg ml "1 ) were scanned in a 0.01 cm pathlength cell using a Jasco-J-715 spectropolarimeter. Spectra are averages of eight scans over a wavelength range of 197-245 nm, with a bandwidth of 2 nm. The results were normalized by subtracting the baseline buffer spectrum from each.
